BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19016016)

  • 1. Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging?
    Studer G; Seifert B; Glanzmann C
    Strahlenther Onkol; 2008 Nov; 184(11):580-5. PubMed ID: 19016016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative IMRT in head and neck cancer.
    Studer G; Furrer K; Davis BJ; Stoeckli SS; Zwahlen RA; Luetolf UM; Glanzmann C
    Radiat Oncol; 2006 Oct; 1():40. PubMed ID: 17052346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
    Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
    Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT.
    Studer G; Luetolf UM; Glanzmann C
    Strahlenther Onkol; 2007 Aug; 183(8):417-23; discussion 424-5. PubMed ID: 17680220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT.
    Studer G; Glanzmann C
    Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
    Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.
    Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.
    Pehlivan B; Luthi F; Matzinger O; Betz M; Dragusanu D; Bulling S; Bron L; Pasche P; Seelentag W; Mirimanoff RO; Zouhair A; Ozsahin M
    Ann Surg Oncol; 2009 May; 16(5):1337-43. PubMed ID: 19280263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.
    Studer G; Lütolf UM; El-Bassiouni M; Rousson V; Glanzmann C
    Acta Oncol; 2007; 46(3):386-94. PubMed ID: 17450476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
    Daly ME; Chen AM; Bucci MK; El-Sayed I; Xia P; Kaplan MJ; Eisele DW
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):151-7. PubMed ID: 17189068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
    Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.